464. Deputy Louise O'Reilly asked the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, the reason the Health Products Regulatory Authority, the HSE or his Department did not as a precautionary measure cease ordering and distributing to participating cancer centres the textured implants of the company (details supplied) in view of the fact there were already significant numbers of reported instances of breast implant associated anaplastic large cell lymphoma attributed to the product [51885/19]

Summary

464. Deputy Louise O'Reilly asked the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, the reason the Health Products Regulatory Authority, the HSE or his Department did not as a precautionary measure cease ordering and distributing to participating cancer centres the textured implants of the company (details supplied) in view of the fact there were already significant numbers of reported instances of breast implant associated anaplastic large cell lymphoma attributed to the product [51885/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Cancer Awareness

  xml · EN · 10 December 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.